TrialThe New England journal of medicine2022

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.

Hervé Tilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.